Free Trial

Stephens Investment Management Group LLC Has $85.83 Million Stock Position in Axon Enterprise, Inc $AXON

Axon Enterprise logo with Aerospace background

Key Points

  • Stephens Investment Management Group LLC has reduced its stake in Axon Enterprise by 38.8%, now holding 103,662 shares valued at approximately $85.83 million.
  • Axon Enterprise reported better-than-expected quarterly earnings, with an EPS of $2.12, exceeding the consensus estimate by $0.58.
  • Analysts maintain a positive outlook on Axon Enterprise, with fourteen analysts giving a Buy rating and an average price target of $841.64.
  • MarketBeat previews the top five stocks to own by November 1st.

Stephens Investment Management Group LLC lowered its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 38.8% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 103,662 shares of the biotechnology company's stock after selling 65,831 shares during the quarter. Axon Enterprise accounts for 1.1% of Stephens Investment Management Group LLC's holdings, making the stock its 25th biggest position. Stephens Investment Management Group LLC owned approximately 0.13% of Axon Enterprise worth $85,826,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Hemington Wealth Management boosted its position in Axon Enterprise by 70.8% during the 2nd quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company's stock worth $33,000 after acquiring an additional 17 shares during the last quarter. TCTC Holdings LLC boosted its position in Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock worth $29,000 after acquiring an additional 24 shares during the last quarter. Bartlett & CO. Wealth Management LLC boosted its position in Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after acquiring an additional 33 shares during the last quarter. Catalyst Capital Advisors LLC acquired a new position in Axon Enterprise during the 1st quarter worth approximately $32,000. Finally, Banque Transatlantique SA acquired a new stake in shares of Axon Enterprise in the 1st quarter valued at approximately $31,000. Institutional investors and hedge funds own 79.08% of the company's stock.

Axon Enterprise Stock Up 3.5%

AXON stock opened at $707.04 on Wednesday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The stock has a market capitalization of $55.51 billion, a price-to-earnings ratio of 174.58, a PEG ratio of 26.53 and a beta of 1.41. The business's fifty day moving average price is $735.50 and its two-hundred day moving average price is $720.82. Axon Enterprise, Inc has a fifty-two week low of $422.38 and a fifty-two week high of $885.91.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.58. The firm had revenue of $668.54 million for the quarter, compared to analysts' expectations of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company's quarterly revenue was up 32.6% compared to the same quarter last year. During the same quarter last year, the business earned $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. On average, equities analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the firm's stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $831.29, for a total value of $8,312,900.00. Following the transaction, the chief executive officer directly owned 3,053,982 shares of the company's stock, valued at $2,538,744,696.78. This trade represents a 0.33% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Hadi Partovi bought 1,358 shares of the firm's stock in a transaction on Wednesday, August 13th. The stock was purchased at an average cost of $740.00 per share, for a total transaction of $1,004,920.00. Following the completion of the acquisition, the director owned 237,938 shares in the company, valued at approximately $176,074,120. This trade represents a 0.57% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders sold 59,932 shares of company stock worth $45,115,616. Corporate insiders own 5.70% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Morgan Stanley set a $885.00 price objective on Axon Enterprise and gave the company an "overweight" rating in a report on Friday, July 11th. JPMorgan Chase & Co. increased their price target on Axon Enterprise from $730.00 to $850.00 and gave the company an "overweight" rating in a research note on Thursday, July 17th. Raymond James Financial restated an "outperform" rating and issued a $855.00 price target (up previously from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Wolfe Research began coverage on Axon Enterprise in a research report on Monday, July 7th. They set an "outperform" rating on the stock. Finally, JMP Securities reiterated a "market outperform" rating and set a $825.00 price objective on shares of Axon Enterprise in a research report on Monday, September 29th. Fourteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $841.64.

Get Our Latest Analysis on Axon Enterprise

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Articles

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Axon Enterprise Right Now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.